We just received data on a new analyst forecast for $CAT. Truist Securities gave a rating of 'Buy' for $CAT.
$CAT Analyst Ratings
Wall Street analysts have issued reports on $CAT in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 10/30/2025
- B of A Securities issued a "Buy" rating on 10/15/2025
- JP Morgan issued a "Overweight" rating on 10/14/2025
- Baird issued a "Outperform" rating on 08/29/2025
- Oppenheimer issued a "Outperform" rating on 08/29/2025
- Evercore ISI Group issued a "Outperform" rating on 08/19/2025
- Morgan Stanley issued a "Underweight" rating on 08/07/2025
To track analyst ratings and price targets for $CAT, check out Quiver Quantitative's $CAT forecast page.
$CAT Price Targets
Multiple analysts have issued price targets for $CAT recently. We have seen 14 analysts offer price targets for $CAT in the last 6 months, with a median target of $504.0.
Here are some recent targets:
- Michael Feniger from B of A Securities set a target price of $650.0 on 10/30/2025
- Jamie Cook from Truist Securities set a target price of $729.0 on 10/30/2025
- Sabahat Khan from RBC Capital set a target price of $560.0 on 10/22/2025
- Adam Seiden from Barclays set a target price of $485.0 on 10/20/2025
- Chad Dillard from Bernstein set a target price of $502.0 on 10/14/2025
- Tami Zakaria from JP Morgan set a target price of $650.0 on 10/14/2025
- Steven Fisher from UBS set a target price of $506.0 on 10/13/2025
$CAT Congressional Stock Trading
Members of Congress have traded $CAT stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CAT stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 05/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CAT Insider Trading Activity
$CAT insiders have traded $CAT stock on the open market 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $CAT stock by insiders over the last 6 months:
- III DONALD J UMPLEBY (Executive Chairman) has made 0 purchases and 3 sales selling 51,500 shares for an estimated $23,703,810.
- SUSAN C SCHWAB sold 2,324 shares for an estimated $952,840
- JASON KAISER (Group President) sold 2,161 shares for an estimated $902,649
- DAVID MACLENNAN purchased 375 shares for an estimated $120,262
- GERALD JOHNSON purchased 100 shares for an estimated $31,848
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CAT Hedge Fund Activity
We have seen 1,433 institutional investors add shares of $CAT stock to their portfolio, and 1,269 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VALEO FINANCIAL ADVISORS, LLC added 7,279,991 shares (+36842.1%) to their portfolio in Q2 2025, for an estimated $2,826,165,306
- CAPITAL WORLD INVESTORS removed 3,488,750 shares (-43.2%) from their portfolio in Q2 2025, for an estimated $1,354,367,637
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,736,631 shares (+1851.8%) to their portfolio in Q3 2025, for an estimated $828,633,481
- BLACKROCK, INC. removed 1,552,615 shares (-4.4%) from their portfolio in Q2 2025, for an estimated $602,740,669
- BANK OF AMERICA CORP /DE/ removed 1,091,841 shares (-17.6%) from their portfolio in Q2 2025, for an estimated $423,863,594
- NUVEEN, LLC added 1,084,122 shares (+84.6%) to their portfolio in Q2 2025, for an estimated $420,867,001
- PRICE T ROWE ASSOCIATES INC /MD/ added 817,473 shares (+78.7%) to their portfolio in Q2 2025, for an estimated $317,351,193
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
